New pill shows promise for tough lung cancer
Disease control
Not yet recruiting
This study tests an experimental pill, BPI-361175, in 30 adults with advanced non-small cell lung cancer that has specific EGFR mutations and has stopped responding to standard treatments. The goal is to check the drug's safety, find the best dose, and see if it can shrink tumors…
Phase: PHASE1, PHASE2 • Sponsor: Xcovery Holdings, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC